Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy

Por De Pascalis, Roberto, Mittereder, Lara, Kennett, Nikki J., Elkins, Karen L.
Publicado no Infect Immun (2016)

Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice

Por De Pascalis, Roberto, Mittereder, Lara, Chou, Alicia Y., Kennett, Nikki J., Elkins, Karen L.
Publicado no PLoS One (2015)

–Water-in-oil only adjuvants selectively promote Tfh polarization through a type I interferon and IL-6 dependent pathway

Por Riteau, Nicolas, Radtke, Andrea J., Shenderov, Kevin, Mittereder, Lara, Oland, Sandra D., Hieny, Sara, Jankovic, Dragana, Sher, Alan
Publicado no J Immunol (2016)

The IL-12 response of primary human DC and monocytes to Toxoplasma gondii is stimulated by phagocytosis of live parasites rather than host cell invasion

Por Tosh, Kevin W., Mittereder, Lara, Bonne-Annee, Sandra, Hieny, Sara, Nutman, Thomas B., Singer, Steven M., Sher, Alan, Jankovic, Dragana
Publicado no J Immunol (2015)

A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis

Por De Pascalis, Roberto, Hahn, Andrew, Brook, Helen M., Ryden, Patrik, Donart, Nathaniel, Mittereder, Lara, Frey, Blake, Wu, Terry H., Elkins, Karen L.
Publicado no PLoS One (2018)

Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy

Por Namasivayam, Sivaranjani, Maiga, Mamoudou, Yuan, Wuxing, Thovarai, Vishal, Costa, Diego L., Mittereder, Lara R., Wipperman, Matthew F., Glickman, Michael S., Dzutsev, Amiran, Trinchieri, Giorgio, Sher, Alan
Publicado no Microbiome (2017)

Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes

Por Costa, Diego L., Namasivayam, Sivaranjani, Amaral, Eduardo P., Arora, Kriti, Chao, Alex, Mittereder, Lara R., Maiga, Mamoudou, Boshoff, Helena I., Barry, Clifton E., Goulding, Celia W., Andrade, Bruno B., Sher, Alan
Publicado no mBio (2016)

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer

Por Bennett, Christina N, Tomlinson, Christine C, Michalowski, Aleksandra M, Chu, Isabel M, Luger, Dror, Mittereder, Lara R, Aprelikova, Olga, Shou, James, Piwinica-Worms, Helen, Caplen, Natasha J, Hollingshead, Melinda G, Green, Jeffrey E
Publicado em 2012